Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
Executive Order Kicks Off 100-Day Review Of US API Framework
A fresh executive order from US president Joe Biden calls for short-term and long-term study, broad consultation, and co-ordination with allies on the domestic supply chain.
You may also be interested in...
US president Joe Biden’s latest executive order directing a review of the API supply chain has been welcomed by the country’s off-patent industry.
Executive orders signed by Joe Biden in the first days of his presidency to support the US pandemic response – including calling for a plan to bolster domestic manufacturing capabilities – have received a warm welcome from the AAM.
US FDA excludes chronic care products from list of medicines bolstered by domestic production investment and federal procurement requirements.